Advertisement
UK markets closed

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     

  • CRUDE OIL

    85.43
    +0.02 (+0.02%)
     

  • GOLD FUTURES

    2,409.30
    +26.30 (+1.10%)
     

  • DOW

    37,885.75
    +150.64 (+0.40%)
     

  • Bitcoin GBP

    50,610.16
    +23.90 (+0.05%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,914.25
    +29.23 (+0.18%)
     

  • UK FTSE All Share

    4,260.41
    -78.49 (-1.81%)
     
Money:

How to avoid tax creep in retirement

The state pension went up 8.5% in April, but frozen thresholds mean pensioners will be paying more tax

Drugmaker GSK returns to growth in China after torrid time

Reuters - UK Focus

LONDON, Oct (HKSE: 3366-OL.HK - news) 26 (Reuters) - GlaxoSmithKline (Other OTC: GLAXF - news) comments on China during third-quarter results:

* CEO Andrew Witty tells analysts GSK is fundamentally back to growth in China

* China business up 24% in third quarter

* Reflects particularly the benefit of wholesaler stocking ahead of a systems upgrade

* Excluding the benefit of wholesaler stocking, sales in China grew around 4%

* GSK's China business has been struggling since bribery scandal in 2013

* GSK has since restructured and refocused its China business

* Overall Q3 results coverage (Reporting by Ben Hirschler)